|
|
[ÇóÖú]
ͶÈÕ±¾CHEM PHARM BULL·µ»ØÐÞ¸ÄÒâ¼û£¬ÓÐÒ»Ìõ¿´²»¶®£¬Âé·³ÓоÑéµÄÅóÓѰïÎÒ½âÊÍһϡ£
¡°General procedure is provided, but the one synthetic pathway of targeted compound with yields is necessary. ¡±
Ö¸µÄÊÇÎÒµÄʵÑ鲿·Ö£¬ËµÎÒÎÄÕÂÀï¸ø³öÁ˺ϳÉͨ·¨£¬µ«ÊÇ¡¡ºó°ë¾äÎÒ¿´µÃÃÔºý¡£
ÎÄÕÂÖÐÿ¸öÄ¿±ê»¯ºÏÎïµÄÊÕÂÊÎÒ¶¼¸øÁ˰¡£¬ËûÊÇÈÃÎÒ²¹³äÕûÌõ·ÏßµÄ×ÜÊÕÂÊÂ𣿣¨¿ÉÊÇÒ»°ãºÃÏñҲû¼ûÓÐÈËÕâôд°É£©
»¹ÊÇ˵ҪÎÒ²¹³äÄÇЩÖмäÌåÖÆ±¸Í¨·¨µÄÊÕÂÊ£¨83-89%ÄÇÖÖ£©£¿£¨ÖƱ¸ÖмäÌåµÄͨ·¨ÎÒûÓÐдÊÕÂÊ£¬¿ÉΪʲôÓÖÊÇ¡°target compounds¡±ÄØ£¿£© |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ10È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
|